Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 4Thoracic 3Tumor-Agnostic 2Other hematologic neoplasm 2Plasma cell 1Lymphoid 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Lung Neoplasms 3Social Stigma 1Motor Activity 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Waiting Lists × Thoracic × Clear all
NCT06191939 2026-04-13

MSC-LC

Loyola Marymount University

Phase NA Completed
79 enrolled
Thoracic

Lung Neoplasms, Social Stigma

NCT05179408 2026-01-27

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

VA Office of Research and Development

Phase NA Recruiting
40 enrolled
Thoracic

Lung Neoplasms

NCT00717795 2023-06-07

Physical Activity Intervention for Lung Cancer Survivors

Memorial Sloan Kettering Cancer Center

Completed
52 enrolled
Thoracic

Lung Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡